Ray Dalio's BNTX Position Overview
Ray Dalio (via Bridgewater Associates, Lp) currently holds 4,927 shares of BioNTech SE (BNTX) worth $469,050, representing 0.00% of the portfolio. First purchased in 2022-Q2, this medium-term investment has been held for 9 quarters.
Based on 13F filings, Ray Dalio has maintained a strategic position in BNTX, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2024, adding 14,604 shares. Largest reduction occurred in Q2 2025, reducing 14,319 shares.
Analysis based on 13F filings available since 2013 Q2
Ray Dalio's BioNTech SE (BNTX) Holding Value Over Time
Track share changes against reported price movement
Quarterly BioNTech SE (BNTX) Trades by Ray Dalio
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +4,927 | New Buy | 4,927 | $95.20 |
| Q2 2025 | -14,319 | Sold Out | 0 | $0.00 |
| Q1 2025 | -5,958 | Reduce 29.38% | 14,319 | $91.06 |
| Q4 2024 | +14,604 | Add 257.43% | 20,277 | $113.95 |
| Q3 2024 | +5,673 | New Buy | 5,673 | $118.77 |
| Q1 2024 | -4,083 | Sold Out | 0 | $0.00 |
| Q4 2023 | +4,083 | New Buy | 4,083 | $105.54 |
| Q3 2022 | -12,156 | Sold Out | 0 | $0.00 |
| Q2 2022 | +12,156 | New Buy | 12,156 | $149.06 |
Ray Dalio's BioNTech SE Investment FAQs
Ray Dalio first purchased BioNTech SE (BNTX) in Q2 2022, acquiring 12,156 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio has held BioNTech SE (BNTX) for 9 quarters since Q2 2022.
Ray Dalio's largest addition to BioNTech SE (BNTX) was in Q4 2024, adding 20,277 shares worth $2.31 M.
According to the latest 13F filing for Q4 2025, Ray Dalio's firm, Bridgewater Associates, Lp, owns 4,927 shares of BioNTech SE (BNTX), valued at approximately $469,050.
As of the Q4 2025 filing, BioNTech SE (BNTX) represents approximately 0.00% of Ray Dalio's publicly disclosed stock portfolio, making it one of their key holdings.
Ray Dalio's peak holding in BioNTech SE (BNTX) was 20,277 shares, as reported at the end of Q4 2024.